Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program.
Kotani D, Takashima A, Kato T, Satoh T, Masuishi T, Komatsu Y, Shiozawa M, Esaki T, Izawa N, Takeuchi S, Bando H, Iwasa S, Hasegawa H, Yamaguchi T, Taniguchi H, Ushida Y, Oizaki T, Inoue C, Yoshino T.
Kotani D, et al. Among authors: inoue c.
Clin Colorectal Cancer. 2024 Jun;23(2):174-182.e6. doi: 10.1016/j.clcc.2024.02.002. Epub 2024 Mar 9.
Clin Colorectal Cancer. 2024.
PMID: 38553360
Free article.